Showing results (231-240 of 292) with videos related to

Sort By:
Pageof 30
Emerging Infectious Diseases|February 25, 2020
Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada1Joanne M Langley, Soren Gantt, Caroline Quach, et al.
Vaccine|November 26, 2011
Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous doseScott A Halperin, David Scheifele, Gaston De Serres, et al.
Human Vaccines & Immunotherapeutics|November 12, 2016
Assessing the risk of intussusception and rotavirus vaccine safety in CanadaSteven Hawken, Robin Ducharme, Laura C Rosella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 19, 2020
Waning Vaccine Immunity and Vaccination Responses in Children Treated for Acute Lymphoblastic Leukemia: A Canadian Immunization Research Network StudyKarina A Top, Wendy Vaudry, Shaun K Morris, et al.
Human Vaccines & Immunotherapeutics|July 11, 2013
Safety, immunogenicity, and tolerability of three influenza vaccines in older adults: results of a randomized, controlled comparisonDavid W Scheifele, Shelly A McNeil, Brian J Ward, et al.
The Journal of Pediatrics|May 15, 2025
Active Surveillance for Myocarditis and Pericarditis in Canadian Children from 2021 to 2022: A Canadian Immunization Monitoring Program ACTive StudyKarina A Top, Julie A Bettinger, Joanne E Embree, et al.
Plos One|June 11, 2025
Immune response induced by the recombinant novel coronavirus vaccine (Adenovirus type 5 vector) (Ad5-nCoV) in persons living with HIV (PLWH)Pedro Cahn, Luis Barreto, Maria Ines Figueroa, et al.
Vaccine|March 2, 2022
Safety and reactogenicity of a liquid formulation of human rotavirus vaccine (porcine circovirus-free): A phase III, observer-blind, randomized, multi-country studyYu-Lung Lau, Ting Fan Leung, Benhur Sirvan Cetin, et al.
BMJ Open|October 7, 2025
Models, frameworks, and strategies used to implement digital interventions targeted to youth mental health: a scoping review protocolStephana Julia Moss, Cristina Zuniga Chacon, Firoozeh Bairami Hekmati, et al.
Vaccine|March 8, 2012
Persistence of the immune response at 5 years of age following infant immunisation with investigational quadrivalent MenACWY conjugate vaccine formulationsAmeneh Khatami, Matthew D Snape, Elizabeth Davis, et al.
Pageof 30